Physician

Thomas Richard Brander, MD

According to 2025 Medicare claims, Thomas Brander, MD (NPI: 1598803330) practices dermatology in the Bloomington, IL market, with the plurality of this provider's patient population coming from Mc Lean, IL. This provider's primary affiliated billing organization is ASSOCIATES IN DERMATOLOGY SC (NPI: 1689863904; TIN: 371098199) and primary practice location at 61701-7904.

Brander's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,763 traditional Medicare patients, billed 7,920 HCPCS/CPT codes, and received $312,037 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,412 prescription claims across 617 beneficiaries totaling $420,212 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 6 records totaling $270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $257,134 to $312,037. Similarly, Part D prescription costs have risen steadily, from $141,703 to $420,212. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$228K$456K2015 Medicare payment: $257,134 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $255,953 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $277,288 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $319,496 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $380,101 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $263,176 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $302,695 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $398,851 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $455,588 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $312,037 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1618,249$257,134
20161,1808,094$255,953
20171,2978,635$277,288
20181,4739,518$319,496
20191,62911,230$380,101
20201,4227,781$263,176
20211,3728,070$302,695
20221,96010,606$398,851
20232,21712,404$455,588
20241,7637,920$312,037

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$210K$420K2015 Drug cost: $141,703 (USD; Tot_Drug_Cst)2016 Drug cost: $103,150 (USD; Tot_Drug_Cst)2017 Drug cost: $165,879 (USD; Tot_Drug_Cst)2018 Drug cost: $165,347 (USD; Tot_Drug_Cst)2019 Drug cost: $64,142 (USD; Tot_Drug_Cst)2020 Drug cost: $105,733 (USD; Tot_Drug_Cst)2021 Drug cost: $125,587 (USD; Tot_Drug_Cst)2022 Drug cost: $194,761 (USD; Tot_Drug_Cst)2023 Drug cost: $337,179 (USD; Tot_Drug_Cst)2024 Drug cost: $420,212 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015342972$141,703
2016311866$103,150
2017367925$165,879
2018353855$165,347
2019384883$64,142
2020415949$105,733
20214671,038$125,587
20225111,244$194,761
20235771,300$337,179
20246171,412$420,212

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth389440$57
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0191,402$56
17000Destruction of precancer skin growth, 1 growth602784$33
88305Pathology examination of tissue using a microscope, intermediate complexity6461,806$19
17003Destruction of precancer skin growth, 2-14 growths4111,482$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab461,232$169,429
AcitretinAcitretin25719$9,693
Clobetasol PropionateClobetasol Propionate892,418$6,016
FluorouracilFluorouracil531,314$4,358
MetronidazoleMetronidazole782,354$3,896

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$270SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas Richard Brander, MD?

Tedicare shows public-source Medicare data for Thomas Richard Brander, MD (NPI 1598803330), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Richard Brander, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas Richard Brander, MD?

Thomas Richard Brander, MD is linked to ASSOCIATES IN DERMATOLOGY SC (billing NPI 1689863904) in the available physician profile data.

Does Thomas Richard Brander, MD have Open Payments data?

Thomas Richard Brander, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.